Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.28−0.05 (-3.76%)
Close on Nov 13, 2026Market cap $217.02MP/E –Yield –
Cabaletta Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cabaletta Bio's operating cash flow for the twelve months ending Sep 30, 2026 was -$162.16M. For fiscal 2025 it was -$131.08M. The highest annual figure on record is -$4.66M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$131.08M | – |
| FY2024 | Dec 31, 2024 | -$88.22M | – |
| FY2023 | Dec 31, 2023 | -$53.55M | – |
| FY2022 | Dec 31, 2022 | -$46.38M | – |
| FY2021 | Dec 31, 2021 | -$34.11M | – |
| FY2020 | Dec 31, 2020 | -$26.77M | – |
| FY2019 | Dec 31, 2019 | -$16.05M | – |
| FY2018 | Dec 31, 2018 | -$4.66M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$42.74M | – |
| Q2 FY2026 | Jun 30, 2026 | -$41.51M | – |
| Q1 FY2026 | Mar 31, 2026 | -$42.56M | – |
| Q4 FY2025 | Dec 31, 2025 | -$35.34M | – |
| Q3 FY2025 | Sep 30, 2025 | -$34.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$30.43M | – |
| Q1 FY2025 | Mar 31, 2025 | -$30.80M | – |
| Q4 FY2024 | Dec 31, 2024 | -$23.12M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.32M | – |
| Q2 FY2024 | Jun 30, 2024 | -$20.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$23.99M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.60M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.89M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.61M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.13M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.91M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.53M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.81M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.34M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.58M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.67M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.17M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.02M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.64M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.93M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.88M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.08M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.82M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.27M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.91M | – |
See a number that looks wrong?